Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study

被引:51
|
作者
Compston, JE
McConachie, C
Stott, C
Hannon, RA
Kaptoge, S
Debiram, I
Love, S
Jaffa, A
机构
[1] Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[2] Phoenix Ctr, Cambridge, England
[3] Addenbrookes Hosp, Bone Metab Unit, Cambridge, England
[4] Addenbrookes Hosp, Dept Med, Cambridge, England
[5] Strangeways Res Lab, Bone Res Grp, Cambridge CB1 4RN, England
[6] Univ Sheffield, Acad Unit Bone Metab, Sheffield, S Yorkshire, England
[7] Dept Dev Psychiat, Cambridge, England
[8] Croft Childrens Unit, Cambridge, England
[9] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England
关键词
anorexia nervosa; body composition; bone mineral density; osteoporosis;
D O I
10.1007/s00198-005-1904-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is a serious complication of anorexia nervosa and in affected adolescents may result in a permanent deficit in bone mass. The pathophysiology of this bone disease has not been clearly defined. In this prospective study of 26 young women with anorexia nervosa aged 13-20 years (mean 16.5) we have measured changes in bone mineral density, total body composition and biochemical indices of bone turnover over 1 year. Over this period there was a mean weight gain of 10 kg and significant height gain with baseline and final values for body mass index of 14.2 +/- 1.7 and 17.6 +/- 2.3 kg/m(2) (P < 0.001). However, no significant changes were seen in bone mineral density in the spine or proximal femur during the study; total body bone mineral content was significantly higher than baseline at 3 months and 12 months (P=0.001 and P < 0.0001), but total body bone mineral density at 3 months was significantly lower than baseline (P=0.003). Serum osteocalcin and bone-specific alkaline phosphatase values increased significantly and remained higher than baseline at all time points whereas urinary NTX/creatinine excretion showed a non-significant increase over the first 6 months of the study, but at 12 months, the mean value was significantly lower than baseline. Mean serum 25-hydroxyvitamin D levels showed a significant decrease at 6 months (P < 0.05), but returned towards baseline thereafter. There was a significant increase in serum parathyroid hormone levels at all time points compared to baseline, these occurring within the normal range. These results indicate that although weight gain in young anorexics is associated with linear growth, bone mineral density does not increase. Whether this deficit can be corrected subsequently requires longer-term prospective studies.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [21] Factors Predicting Bone Mineral Density (BMD) Changes in Young Women over A One-year Study: Changes in Body Weight and Bone Metabolic Markers during the Menstrual Cycle and Their Effects on BMD
    Iida, Tadayuki
    Chikamura, Chiho
    Ishikawa, Hiroaki
    Aoi, Satomi
    Ikeda, Hiromi
    Harada, Toshihide
    Katada, Kazuhiro
    Ishizaki, Fumiko
    Yatsuya, Hiroshi
    Ono, Yuichiro
    ACTA MEDICA OKAYAMA, 2012, 66 (04) : 307 - 315
  • [22] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    A. Blumsohn
    F. Marin
    T. Nickelsen
    K. Brixen
    G. Sigurdsson
    J. González de la Vera
    S. Boonen
    S. Liu-Léage
    C. Barker
    R. Eastell
    Osteoporosis International, 2011, 22 : 1935 - 1946
  • [23] Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
    McClung, M. R.
    Lewiecki, E. M.
    Geller, M. L.
    Bolognese, M. A.
    Peacock, M.
    Weinstein, R. L.
    Ding, B.
    Rockabrand, E.
    Wagman, R. B.
    Miller, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (01) : 227 - 235
  • [24] Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
    M. R. McClung
    E. M. Lewiecki
    M. L. Geller
    M. A. Bolognese
    M. Peacock
    R. L. Weinstein
    B. Ding
    E. Rockabrand
    R. B. Wagman
    P. D. Miller
    Osteoporosis International, 2013, 24 : 227 - 235
  • [25] The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial
    G. Grimnes
    R. Joakimsen
    Y. Figenschau
    P. A. Torjesen
    B. Almås
    R. Jorde
    Osteoporosis International, 2012, 23 : 201 - 211
  • [26] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    Blumsohn, A.
    Marin, F.
    Nickelsen, T.
    Brixen, K.
    Sigurdsson, G.
    Gonzalez de la Vera, J.
    Boonen, S.
    Liu-Leage, S.
    Barker, C.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1935 - 1946
  • [27] Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study
    Moller, U. K.
    Streym, S. Vid
    Mosekilde, L.
    Rejnmark, L.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (04) : 1213 - 1223
  • [28] Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study
    U. K. Møller
    S. við Streym
    L. Mosekilde
    L. Rejnmark
    Osteoporosis International, 2012, 23 : 1213 - 1223
  • [29] A 10-Year Prospective Study of Bone Mineral Density and Bone Turnover in Males and Females With Type 1 Diabetes
    Hamilton, Emma J.
    Drinkwater, Jocelyn J.
    Chubb, S. A. Paul
    Rakic, Valentina
    Kamber, Niklaus
    Zhu, Kun
    Prince, Richard L.
    Davis, Wendy A.
    Davis, Timothy M. E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (09) : 3531 - 3539
  • [30] The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial
    Grimnes, G.
    Joakimsen, R.
    Figenschau, Y.
    Torjesen, P. A.
    Almas, B.
    Jorde, R.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 201 - 211